Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Eleanor A. Smith

Managing Director, Corporate & Healthcare Practice Groups

Eleanor A. Smith

Managing Director, Corporate & Healthcare Practice Groups

Eleanor Smith joined Bass, Berry & Sims PLC in 2005. She is currently the Managing Director for the Corporate & Securities and Healthcare Practice Groups. She is responsible for strategic planning and implementation related to client development, service and satisfaction.

Eleanor has more than 15 years of business development and practice management experience. With respect to business development, her primary focus is on attracting work for the firm, devising strategies for expanding client relationships, building national brand awareness, creating successful individual business development plans as well as attracting lateral talent critical to the growth of the firm. Her practice management responsibilities include analyzing and reporting on financial performance; monitoring utilization and resolving productivity and staffing matters; advising on recruiting decisions; leading lateral integration; and facilitating communication between practice groups and client teams with respect to cross-selling and other collaborative activities.

Eleanor is focused on certain strategic service areas for these practices including mergers and acquisitions, public company advisory, private equity, healthcare regulatory, operations and compliance, and resolving software vendor issues for hospitals.

Eleanor helped design two important strategic events for the firm, the Health Care Investors Conference connecting healthcare providers with potential private equity sponsors and the Specialty Pharmacy CLE program, one of the only programs available for in-house counsel in this industry.

Eleanor is a member of the Nashville Health Care Council's Leadership Health Care and the American Health Lawyers Association. She is a past Chair of the Nashville Chapter of the Legal Marketing Association. She has served on the board of directors for Our Kids, Inc. since 2006 and was a 2013 Nashville Emerging Leader Award Finalist in the category of business services. 

Memberships

American Health Lawyers Association (AHLA)

News

View More

Upcoming Events

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.